Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TinniStop is an over-the-counter homeopathic combination product marketed for the temporary relief of tinnitus-associated symptoms such as ringing, buzzing, and humming in the ears, as well as vertigo, dizziness, and nausea. It was developed by TinniStop and described as a patent-pending formulation announced in 2017, with manufacturing performed by Peerless Homeopathic. The product contains highly diluted HPUS-listed ingredients causticum, conium maculatum, and cocculus indicus. Its claimed therapeutic rationale is based on homeopathic principles rather than a pharmacologically validated target-based mechanism, and there is no established conventional mechanism of action or FDA-evaluated evidence of safety or efficacy for tinnitus treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TinniStop.